[an error occurred while processing this directive] | [an error occurred while processing this directive]
Progress in diagnosis and treatment of local recurrence after radical radiotherapy for esophageal cancer
Li Ruiqing,Cao Liang,Zhao Kuaile
Department of Radiation Oncology,Tai′an Tumour Prevention and Treatment Hospital,Tai′an 271000,China (Li RQ,Cao L);Department of Radiation Oncology,Cancer Hospital of Fudan University,Shanghai 200032,China (Zhao KL)
Abstract The diagnosis of local recurrence after radiochemotherapy for esophageal cancer requires the combination of multiple imaging methods (esophageal X-ray, computed tomography, endoscopic ultrasonography, and positron emission tomography-computed tomography), dynamic changes in esophagoscopy, and biopsy. The main treatment of recurrence includes salvage surgery, radiochemotherapy, endoscopic mucosal resection, and chemotherapy. The overall survival rate after the above treatment is improved compared with palliative care but still unsatisfactory. Early diagnosis of recurrence is fundamental for improved treatment outcomes.
Li Ruiqing,Cao Liang,Zhao Kuaile. Progress in diagnosis and treatment of local recurrence after radical radiotherapy for esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(9): 1020-1024.
Li Ruiqing,Cao Liang,Zhao Kuaile. Progress in diagnosis and treatment of local recurrence after radical radiotherapy for esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(9): 1020-1024.
[1] 谭立君,刘晓,肖泽芬,等.592例食管癌3DRT的预后分析[J].中华放射肿瘤学杂志,2015,24(1):10-15.DOI:10.3760/cma.j.issn.1004-4221.2015.01.004. Tan LJ,Liu X,Xiao ZF,et al. Analysis of outcomes and prognostic factors in 592 esophageal cancer patients treated with three-dimensional radiotherapy[J].Chin J Radiat Oncol,2015,24(1):10-15.DOI:10.3760/cma.j.issn.1004-4221.2015.01.004. [2] Zhao KL,Ma JB,Liu G,et al. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma:is elective nodal irradiation necessary?[J].Int J Radiat Oncol Biol Phys,2010,76(2):446-451.DOI:10.1016/j.ijrobp.2009.02.078. [3] Welsh J,Settle SH,Amini A,et al. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation[J].Cancer,2012,118(10):2632-2640.DOI:10.1002/cncr.26586. [4] Jones DR,Parker LA Jr,Detterbeck FC,et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy[J].Cancer,1999,85(5):1026-1032.DOI:10.1002/(SICI)1097-0142(19990301)85:5<1026::AID-CNCR3>3.0.CO;2-N. [5] Ribeiro A,Franceschi D,Parra J,et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer[J].Am J Gastroenterol,2006,101(6):1216-1221.DOI:10.1111/j.1572-0241.2006.00692.x. [6] Zuccaro G Jr,Rice TW,Goldblum J,et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer[J].Am J Gastroenterol,1999,94(4):906-912.DOI:10.1111/j.1572-0241.1999.985_h.x. [7] Kalha I,Kaw M,Fukami N,et al. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy[J].Cancer,2004,101(5):940-947.DOI:10.1002/cncr.20429. [8] Jost C,Binek J,Schuller JC,et al. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer:a prospective multicenter phase Ⅱ study by the Swiss group for clinical cancer research (SAKK 75/02)[J].Gastrointest Endosc,2010,71(7):1114-1121.DOI:10.1016/j.gie.2009.12.015. [9] Swisher SG,Maish M,Erasmus JJ,et al. Utility of PET,CT,and EUS to identify pathologic responders in esophageal cancer[J].Ann Thorac Surg,2004,78(4):1152-1160.DOI:10.1016/j.athoracsur.2004.04.046. [10] Wieder HA,Brücher BLDM,Zimmermann F,et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment[J].J Clin Oncol,2004,22(5):900-908.DOI:10.1200/JCO.2004.07.122. [11] Gillham CM,Lucey JA,Keogan M,et al.18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response[J].Br J Cancer,2006,95(9):1174-1179.DOI:10.1038/sj.bjc.6603412. [12] Kwee RM.Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET:a systematic review[J].Radiology,2010,254(3):707-717.DOI:10.1148/radiol.09091324. [13] Schneider PM,Metzger R,Schaefer H,et al. Response evaluation by endoscopy,rebiopsy,and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer[J].Ann Surg,2008,248(6):902-908.DOI:10.1097/SLA.0b013e31818f3afb. [14] Shaukat A,Mortazavi A,Demmy T,et al. Should preoperative,post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?[J].Dis Esophagus,2004,17(2):129-135.DOI:10.1111/j.1442-2050.2004.00389.x. [15] Yang Q,Cleary KR,Yao JC,et al. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen[J].Dis Esophagus,2004,17(1):38-43.DOI:10.1111/j.1442-2050.2004.00355.x. [16] Peng HQ,Halsey K,Sun CCJ,et al. Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma[J].Cancer Cytopathol,2009,117(6):463-472.DOI:10.1002/cncy.20051. [17] Bates BA,Detterbeck FC,Bernard SA,et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma[J].J Clin Oncol,1996,14(1):156-163. [18] 严洁华,徐国镇,李素艳,等.对局部顽固性鼻咽癌处理的研究(三)——加量照射随机分组研究结果[J].中国放射肿瘤学,1990,4(1):17-20. Yan JH,Xu GZH,Li SY,et al. A study on the treatment of locally intractable nasopharyngeal carcinoma (3)——The results of random grouping study with adding dose[J].Chin J Radiat Oncol,1990,4(1):17-20. [19] Yano T,Muto M,Hattori S,et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma[J].Endoscopy,2008,40(9):717-721.DOI:10.1055/s-2008-1077480. [20] Yano T,Muto M,Minashi K,et al. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma[J].Endoscopy,2011,43(8):657-663.DOI:10.1055/s-0030-1256373. [21] Yano T,Muto M,Minashi K,et al. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma:a phase Ⅱ study[J].Int J Cancer,2012,131(5):1228-1234.DOI:10.1002/ijc.27320. [22] Yano T,Muto M,Minashi K,et al. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer[J].Gastrointest Endosc,2005,62(1):31-36.DOI:10.1016/S0016-5107(05)00545-6. [23] Malhi-Chowla N,Wolfsen HC,Woodward TA.The value of photodynamic therapy in the treatment of recurrent esophageal cancer after chemoradiation therapy[J].Lasers Surg Med,1999,24(S11):71. [24] Wolfsen HC,Hemminger LL.Salvage photodynamic therapy for persistent esophageal cancer after chemoradiation therapy[J].Photodiagnosis Photodyn Ther,2006,3(1):11-14.DOI:10.1016/S1572-1000(06)00002-0. [25] Lecleire S,Di Fiore F,Antonietti M,et al. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent[J].Am J Gastroenterol,2008,103(9):2215-2219.DOI:10.1111/j.1572-0241.2008.02042.x. [26] Mashimo Y,Hori K,Yukawa Y,et al. Photodynamic therapy (PDT) as a salvage treatment for local failures at primary site after CRT for esophageal cancer[J].Gastrointest End,62(1):31-36.DOI:10.1016/S0016-5107(05)00545-6. [27] Nagahisa E,Yano T,Minashi K,et al. Photodynamic therapy for local failure after chemoradiotherapy for patients with unresectable locally advanced esophageal squamous cell carcinoma[J].Gastrointest Endosc,2010,71(5):AB237.DOI:10.1016/j.gie.2010.03.496. [28] Markar S,Gronnier C,Duhamel A,et al. Salvage surgery after chemoradiotherapy in the management of esophageal cancer:is it a viable therapeutic option?[J].J Clin Oncol,2015,33(33):3866-3873.DOI:10.1200/JCO.2014.59.9092. [29] Sudo K,Xiao LC,Wadhwa R,et al. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer[J].J Clin Oncol,2014,32(30):3400-3405.DOI:10.1200/JCO.2014.56.7156. [30] Swisher SG,Wynn P,Putnam JB,et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy[J].J Thorac Cardiovasc Surg,2002,123(1):175-183.DOI:10.1067/mtc.2002.119070. [31] Nakamura T,Hayashi K,Ota M,et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer[J].Am J Surg,2004,188(3):261-266.DOI:10.1016/j.amjsurg.2004.06.003. [32] Tomimaru Y,Yano M,Takachi K,et al. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy[J].J Surg Oncol,2006,93(5):422-428.DOI:10.1002/jso.20475. [33] Tachimori Y,Kanamori N,Uemura N,et al. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma[J].J Thorac Cardiovasc Surg,2009,137(1):49-54.DOI:10.1016/j.jtcvs.2008.05.016. [34] Chao YK,Chan SC,Chang HK,et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus[J].Eur J Surg Oncol,2009,35(3):289-294.DOI:10.1016/j.ejso.2008.02.014. [35] Morita M,Kumashiro R,Hisamatsu Y,et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy[J].J Gastroenterol,2011,46(11):1284-1291.DOI:10.1007/s00535-011-0448-0. [36] Zhou ZG,Zhen CJ,Bai WW,et al. Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy[J].Radiat Oncol,2015,10:54.DOI:10.1186/s13014-015-0358-z. [37] Kim YS,Lee CG,Kim KH,et al. Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy[J].Radiat Oncol J,2012,30(4):182-188.DOI:10.3857/roj.2012.30.4.182. [38] Teli MA,Mushood GN,Zargar SA,et al. Comparative evaluation between re-irradiation and demand endoscopic dilatation vs. endoscopic dilatation alone in patients with recurrent/reactivated residual in-field esophageal malignancies[J].J Cancer Res Ther,2008,4(3):121-125.DOI:10.4103/0973-1482.43140. [39] Chen Y,Lu Y,Wang Y,et al. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone[J].Dis Esophagus,2014,27(2):134-140.DOI:10.1111/j.1442-2050.2012.01440.x. [40] 沈文斌,祝淑钗,万钧,等.42例放疗后复发食管癌三维适形放疗的疗效分析[J].中华放射肿瘤学杂志,2010,19(2):111-114.DOI:10.3760/cma.j.issn.1004-4221.2010.02.007. Shen WB,Zhu SHC,Wan J,et al. Analysis of the curative effect of three dimensional conformal radiotherapy for recurrent esophageal cancer after radiotherapy in 42 cases[J].Chin J Radiat Oncol,2010,19(2):111-114.DOI:10.3760/cma.j.issn.1004-4221.2010.02.007. [41] 贾丽,王仁本,于金明,等.食管癌放疗后复发的再放疗32例疗效观察[J].中华肿瘤防治杂志,2006,13(11):863-864.DOI:10.3969/j.issn.1673-5269.2006.11.017. Jia L,Wang RB,Yu JM,et al. Curative effect observation of 32 patients with esophageal cancer after radiotherapy[J].Chin J Cancer Prevent Treat,2006,13(11):863-864.DOI:10.3969/j.issn.1673-5269.2006.11.017. [42] 何斌,殷红梅,崔珍,等.食管癌放疗后局部复发45例再程调强放疗分析[J].蚌埠医学院学报,2015,40(1):23-25.DOI:10.13898/j.cnki.issn.1000-2200.2015.01.007. He B,Yin HM,Cui ZH,et al. Analysis of local recurrence in 45 patients with esophageal cancer after radiotherapy[J].J Bengbu Med College,2015,40(1):23-25.DOI:10.13898/j.cnki.issn.1000-2200.2015.01.007. [43] Nieder C,Milas L,Ang KK.Tissue tolerance to reirradiation[J].Semin Radiat Oncol,2000,10(3):200-209.DOI:10.1053/srao.2000.6593. [44] Nieder C,Grosu AL,Andratschke NH,et al. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients[J].Int J Radiat Oncol Biol Phys,2006,66(5):1446-1449.DOI:10.1016/j.ijrobp.2006.07.1383.
2016, Vol. 25 
